Tg Therapeutics (TGTX) Asset Utilization Ratio (2016 - 2025)
Historic Asset Utilization Ratio for Tg Therapeutics (TGTX) over the last 10 years, with Q3 2025 value amounting to 0.62.
- Tg Therapeutics' Asset Utilization Ratio rose 1478.59% to 0.62 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.62, marking a year-over-year increase of 1478.59%. This contributed to the annual value of 0.73 for FY2024, which is 1880.92% down from last year.
- Latest data reveals that Tg Therapeutics reported Asset Utilization Ratio of 0.62 as of Q3 2025, which was up 1478.59% from 0.67 recorded in Q2 2025.
- Tg Therapeutics' Asset Utilization Ratio's 5-year high stood at 0.9 during Q2 2024, with a 5-year trough of 0.0 in Q1 2021.
- In the last 5 years, Tg Therapeutics' Asset Utilization Ratio had a median value of 0.12 in 2023 and averaged 0.34.
- In the last 5 years, Tg Therapeutics' Asset Utilization Ratio surged by 512730.01% in 2023 and then crashed by 2537.97% in 2025.
- Tg Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.02 in 2021, then dropped by 20.16% to 0.01 in 2022, then soared by 5127.3% to 0.71 in 2023, then fell by 20.06% to 0.57 in 2024, then increased by 8.9% to 0.62 in 2025.
- Its Asset Utilization Ratio stands at 0.62 for Q3 2025, versus 0.67 for Q2 2025 and 0.63 for Q1 2025.